SIU investigating man's death after police administered naloxone - Action News
Home WebMail Saturday, November 23, 2024, 04:18 PM | Calgary | -11.6°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Toronto

SIU investigating man's death after police administered naloxone

Ontario's Special Investigation Unit is probing a man's death after he was administered the anti-overdose drug naloxone by police in Brampton early Monday morning.

Peel police also delivered CPR to man in Brampton early Monday

Naloxone temporarily blocks the effects of an opioid overdose but can cause symptoms of withdrawal. (Sam Colbert/CBC)

Ontario's Special Investigation Unit is probing a man's death after he was administered the anti-overdose drug naloxone by police in Brampton early Monday morning.

Peel Regional Police responded to a medical assistance call at a home in the area of McLaughlin Road and Queen Street West at approximately 12:30 a.m., the police watchdog says.

Officers began CPR and administered naloxone to the man. He was later pronounced dead at the scene.

Push back against naloxoneSIU investigations

Earlier this year, theOntario Association of Chiefs of Police's presidentsaidhe was "concerned" about the SIU's position that police must advise the agency whenever a death occurs during police interaction, particularly if naloxone was administered or attempted.

He asked for clarification of the SIU's policy, noting that British Columbia determined similar incidents are "are not SIU matters."

The head of theSIUresponded to OACPsaying Ontario's chiefs of police must "immediately" notify their forces' civilian oversight body if an officer administers the anti-overdose drug naloxone in the line of duty.

The SIU said incidents where police have administered CPR or emergency first aid are "regularly" passed on to the SIU and said he saw no reason make an exception for naloxone.

TheSIUis asking for those with information about the man's death to contact the lead investigator at 1-800-787-8529.

With files from CBC News